ATC Group: M03B Muscle relaxants, centrally acting agents

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M03B in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M03 Muscle relaxants
3 M03B Muscle relaxants, centrally acting agents

Group M03B contents

Code Title
M03BA Carbamic acid esters
M03BB Oxazol, thiazine, and triazine derivatives
M03BC Ethers, chemically close to antihistamines
M03BX Other centrally acting agents

Active ingredients in M03B

Active Ingredient Description
Baclofen

Baclofen is an antispastic agent acting at the spinal level. A gamma-aminobutyric acid (GABA) derivative, chemically unrelated to other antispastic agents.

Carisoprodol

Carisoprodol is a centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Most common adverse reactions (incidence > 2%) are drowsiness, dizziness, and headache. Carisoprodol might be mixtured with Aspirin and Codeine Phosphate.

Chlormezanone
Chlorzoxazone

Chlorzoxazone is a centrally-acting agent for painful musculoskeletal conditions. Data available from animal experiments as well as human study indicate that chlorzoxazone acts primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits multisynaptic reflex arcs involved in producing and maintaining skeletal muscle spasm of varied etiology.

Cyclobenzaprine

Cyclobenzaprine relieves skeletal muscle spasm of local origin without interfering with muscle function. Cyclobenzaprine has not been shown to be effective in muscle spasm due to central nervous system disease.

Eperisone

Eperisone is an antispastic agent used for treatment of diseases characterized by muscle stiffness and pain.

Fenyramidol
Mephenesin
Methocarbamol

Methocarbamol is a centrally acting muscle relaxant. Its muscle relaxing action is the result of the inhibition of polysynaptic reflexes in the spinal marrow and subcortical centres.

Orphenadrine

Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism.

Phenprobamate
Pridinol

Pridinol is a piperidin- polyalcohol derivative with the chemical formula 1,1-Diphenyl-1-ol-3-piperidin-propan-methanesulfonate. Its pharmacological effect develops via an atropine-like mechanism that acts on both smooth and the striated muscles. This effect is used for the treatment of skeletal muscle tension of both central and peripheral origin.

Tetrazepam
Thiocolchicoside

Thiocolchicoside is a semisynthetic sulphide derivative of colchicoside, showing muscle relaxant pharmacological activity. In vitro thiocolchicoside binds solely with gaba receptors and glycinergic stricnine sensitive.Tivozanib

Tizanidine

Tizanidine is a centrally acting skeletal muscle relaxant. Polysynaptic signal transmission at spinal interneuron level, which is responsible for excessive muscle tone, is inhibited and muscle tone reduced.

Tolperisone

As a skeletal muscle relaxant whose prototype is mephenesine, tolperisone induces ataxia and muscle weakness in animal models by acting on the central nervous system at the spinal level. In fact it inhibits polysynaptic and monosynaptic reflexes with little action on non-reflex muscle response and without potentiating the phenobarbital sleep.

Related product monographs

Title Information Source Document Type  
BESEMAX Tablet Health Products Regulatory Authority (ZA) MPI, Generic
COLMIFEN Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
FLEXERIL Tablet Health Products and Food Branch (CA) MPI, CA: SPM
GABLOFEN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
LIORESAL Solutions for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MYDOFLEX Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
MYONAL Tablets / Granules MPI, US: SPL/PLR
MYOPRIDIN Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NORGESIC Tablet, uncoated Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC
ROBAXIN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
ZANAFLEX Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC